CRISPR Therapeutics
CRSP
CRSP
387 hedge funds and large institutions have $2.19B invested in CRISPR Therapeutics in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 119 increasing their positions, 102 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
387
Holders Change
-11
Holders Change %
-2.76%
% of All Funds
5.26%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
54
Increased
119
Reduced
102
Closed
59
Calls
$96.3M
Puts
$75.6M
Net Calls
+$20.7M
Net Calls Change
+$30.7M
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
$66.5M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$346M |
| 3 |
Two Sigma Investments
New York
|
$40.5M |
| 4 |
Morgan Stanley
New York
|
$44.2M |
| 5 |
Two Sigma Advisers
New York
|
$27.1M |
